Literature DB >> 17446202

New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.

Nir Giladi1, Nina Weitzman, Shaul Schreiber, Herzel Shabtai, Chava Peretz.   

Abstract

Alterations of impulse control that have recently been associated with Parkinson's disease (PD) are serious behavioural disturbances with significant impact on PD patients and their families.A total of 193 consecutive PD patients with no history of psychiatric illness and 190 age/gender-matched healthy controls were queried on the presence of new onset heightened interest or drive for gambling, shopping, eating or sexual activity (GSES). Clinical data were retrieved from medical charts and interviews. logistic regressions models assessed risk factors for these specific troublesome behaviours. New or heightened interests or drives for GSES behaviours were reported by 27 patients (14% vs 0% for controls). Younger age at PD motor symptoms onset (OR = 0.99, p = 0.0172), male gender (OR = 1.10, p = 0.0576) and longer duration of treatment with dopamine agonists (DAs)(OR = 1.18, >/=6 years versus never treated, p = 0.0459) contributed additively to the risk of developing one or more of these behavioural features. New onset heightened interests or drives for GSES are not rare behavioural disturbances among patients with PD. Age, gender and duration of treatment with DAs have an independent and additive effect on the risk to develop such behavioural changes. Patients should be informed about potential treatment-associated behavioural changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446202     DOI: 10.1177/0269881106073109

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  37 in total

1.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Effects of acute pramipexole on male rats' preference for gambling-like rewards II.

Authors:  Patrick S Johnson; Gregory J Madden; Jeffrey S Stein
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-30       Impact factor: 3.157

3.  Neuropsychological features of patients with Parkinson's disease and impulse control disorders.

Authors:  Anna Rita Bentivoglio; Eleonora Baldonero; Lucia Ricciardi; Francesca De Nigris; Antonio Daniele
Journal:  Neurol Sci       Date:  2012-11-18       Impact factor: 3.307

4.  Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.

Authors:  Daniel Weintraub; Kimberly Papay; Andrew Siderowf
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

5.  Pramipexole-induced disruption of behavioral processes fundamental to intertemporal choice.

Authors:  Patrick S Johnson; Jeffrey S Stein; Rochelle R Smits; Gregory J Madden
Journal:  J Exp Anal Behav       Date:  2013-02-22       Impact factor: 2.468

Review 6.  Impulse control disorders in Parkinson's disease.

Authors:  Ana Marques; Franck Durif; Pierre-Olivier Fernagut
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

7.  Impulse control disorders in Parkinson's disease: clinical characteristics and implications.

Authors:  Robert F Leeman; Marc N Potenza
Journal:  Neuropsychiatry (London)       Date:  2011-04

8.  Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.

Authors:  Silvia Cabrini; Mario Baratti; Flavio Bonfà; Giulio Cabri; Elena Uber; Maurizio Avanzi
Journal:  Neurol Sci       Date:  2009-06-10       Impact factor: 3.307

Review 9.  Parasomnias: an updated review.

Authors:  Michael J Howell
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

10.  Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.

Authors:  Daniel Weintraub; Staci Hoops; Judy A Shea; Kelly E Lyons; Rajesh Pahwa; Erika D Driver-Dunckley; Charles H Adler; Marc N Potenza; Janis Miyasaki; Andrew D Siderowf; John E Duda; Howard I Hurtig; Amy Colcher; Stacy S Horn; Matthew B Stern; Valerie Voon
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.